| 1 |
35463964 | Structural Basis of Human Dimeric α-Amino-β-Carboxymuconate-ε-Semialdehyde Decarboxylase Inhibition With TES-1025. | 2022 |
2 |
| 2 |
30799186 | ACMSD: A Novel Target for Modulating NAD+ Homeostasis. | 2019 Apr |
10 |
| 3 |
29345930 | α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of De Novo Nicotinamide Adenine Dinucleotide (NAD+) Biosynthesis. | 2018 Feb 8 |
7 |
| 4 |
30380424 | Alpha-Amino-Beta-Carboxy-Muconate-Semialdehyde Decarboxylase Controls Dietary Niacin Requirements for NAD+ Synthesis. | 2018 Oct 30 |
2 |
| 5 |
29103054 | Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson's Disease? | 2017 |
1 |
| 6 |
25392945 | Human α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD): a structural and mechanistic unveiling. | 2015 Jan |
1 |
| 7 |
19843166 | The crystal structure of human alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase in complex with 1,3-dihydroxyacetonephosphate suggests a regulatory link between NAD synthesis and glycolysis. | 2009 Nov |
1 |